Glioblastoma

Glioblastoma is an aggressive brain tumor with limited treatment options and poor outcomes. ALDH1A3 expression in glioblastoma cells promotes therapy resistance and tumor invasiveness, positioning it as a key target for therapies aimed at improving survival and quality of life for patients.